Collegium Pharmaceutical
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Collegium Pharmaceutical's past years’ income statements indicate that its last revenue has increased compared to the previous period by 22% to $566,767,000. The net income raised on $48,155,000 and profit margin reached 8%. Total operating expenses were $159,208,000.
Profit Margin
| 2014 | 0 | -17.91M | |
|---|---|---|---|
| 2015 | 0 | -27.25M | |
| 2016 | 1.71M | -94.17M | -5504.15% |
| 2017 | 28.47M | -74.86M | -262.91% |
| 2018 | 280.41M | -39.12M | -13.95% |
| 2019 | 296.70M | -8.14M | -2.75% |
| 2020 | 310.01M | 26.75M | 8.63% |
| 2021 | 276.86M | 71.51M | 25.83% |
| 2022 | 463.93M | -25.00M | -5.39% |
| 2023 | 566.76M | 48.15M | 8.5% |
COLL Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 566.76M | 463.93M | 276.86M | 310.01M | 296.70M | 280.41M | 28.47M | 1.71M | 0 | 0 |
Cost of revenue | 240.59M | 254.44M | 126.25M | 130.18M | 193.66M | 165.67M | 2.59M | 213K | 171K | 0 |
Gross profit | 326.16M | 209.48M | 150.61M | 179.83M | 103.04M | 114.73M | 25.88M | 1.49M | -171K | 0 |
Operating exp. | ||||||||||
Research and development | 0 | 3.98M | 9.45M | 9.77M | 10.34M | 8.66M | 8.57M | 14.94M | 7.97M | 14.95M |
Selling and marketing | 7.40M | 11.74M | 4.18M | 5.36M | 116.44M | 126.76M | 92.75M | 80.63M | 0 | 0 |
Total operating expenses | 159.20M | 176.16M | 128.41M | 123.60M | 126.78M | 135.42M | 101.32M | 95.58M | 26.90M | 17.66M |
Operating income | 166.96M | -104.57M | -46.69M | -5.08M | -23.74M | -20.68M | -75.44M | -94.08M | -26.90M | -17.66M |
Other income (expenses), net | -91.22M | 75.72M | 43.32M | -28.65M | 1.02M | -18.44M | 582K | -94K | -348K | -252K |
Income before tax | 75.73M | -28.84M | -3.37M | 27.58M | -22.72M | -39.12M | -74.86M | -94.17M | -27.25M | -17.91M |
Income tax expense | 27.57M | -3.84M | -74.89M | 830K | -14.57M | -110.90M | -1.16M | 94K | -91K | 252K |
Net income | 48.15M | -25.00M | 71.51M | 26.75M | -8.14M | -39.12M | -74.86M | -94.17M | -27.25M | -17.91M |
Earnings per share | ||||||||||
Basic EPS | 1.6 | -0.74 | 2.05 | 0.78 | -0.24 | -1.19 | -2.47 | -3.88 | -2.01 | -2.4 |
Diluted EPS | 1.29 | -0.74 | 1.86 | 0.76 | -0.24 | -1.19 | -2.47 | -3.88 | -2.01 | -2.4 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |